This additional approval of its new manufacturing facility for pegfilgrastim in Bengaluru will enable the biotechnology major to enable its arm Biocon Biologics and Mylan to scale up capacity multi-fold and address the growing market opportunities in US and other global markets.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OMfreG
via IFTTT
0 comments:
Post a Comment